Medication allergy is an abnormal immune system response to a drug or one of its ingredients, and understanding it is essential for safe prescribing and patient care. Unlike predictable side effects, a true allergic reaction involves the immune system mistakenly identifying a medicine as harmful — a distinction that has significant implications for future treatment decisions. From mild skin rashes to life-threatening anaphylaxis, reactions vary widely in severity. In the UK, NICE guideline CG183 provides the core framework for diagnosis and management, yet allergy is frequently over-reported and under-investigated. This article explains what medication allergy is, how it is diagnosed, and how to stay safe.

What Is a Medication Allergy?

A medication allergy is an abnormal immune system response to a drug or one of its ingredients. It is important to distinguish a true allergic reaction from other types of adverse drug reactions (ADRs). ADRs are broadly classified as Type A (predictable, dose-related reactions that can occur in anyone, such as nausea from antibiotics) and Type B (unpredictable reactions, including immune-mediated allergy and non-immune intolerance). A true allergic reaction involves the immune system mistakenly identifying a medicine as a harmful substance; this is different from a side effect or a non-allergic intolerance, and the distinction matters greatly for future prescribing decisions.

Experiencing these side effects? Our pharmacists can help you navigate them →

Medication allergies can occur with both prescription and over-the-counter medicines. Commonly implicated drugs include antibiotics (particularly penicillins and cephalosporins), non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, aspirin, anticonvulsants, and contrast media (iodinated or gadolinium-based agents used in medical imaging). However, virtually any medicine has the potential to trigger an allergic response in a susceptible individual. It is also worth noting that excipients — inactive ingredients such as polyethylene glycol (PEG), polysorbate, or gelatin — can occasionally cause allergic reactions in their own right.

The underlying mechanism often involves immunoglobulin E (IgE)-mediated hypersensitivity, where the immune system produces IgE antibodies against the drug. On subsequent exposure, these antibodies trigger the release of histamine and other inflammatory mediators, producing the characteristic symptoms of allergy. However, many reactions involve different immune pathways. T-cell–mediated delayed hypersensitivity is responsible for a group of serious skin reactions known as severe cutaneous adverse reactions (SCARs), which include Stevens–Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalised exanthematous pustulosis (AGEP). Many NSAID reactions and most reactions to contrast media are non-IgE-mediated (sometimes called 'allergic-like' or pharmacological reactions, including COX-1 inhibition for NSAIDs), rather than true IgE allergy. ACE inhibitor–induced angioedema is another important example of a non-allergic, bradykinin-mediated reaction that is frequently confused with allergy.

The Medicines and Healthcare products Regulatory Agency (MHRA) and NHS guidance both emphasise the importance of accurately documenting and reporting suspected medication allergies to ensure patient safety across care settings. NICE guideline CG183 (Drug allergy: diagnosis and management) provides the core UK framework for this.

Common Signs and Symptoms to Be Aware Of

The signs and symptoms of a medication allergy can range from mild and localised to severe and life-threatening. Recognising these early is essential for prompt and appropriate management.

Immediate reactions typically appear within minutes to two hours of taking the medicine and are more likely to be IgE-mediated. Delayed reactions may develop days or even weeks after starting a medicine — for example, DRESS typically has a latency of two to eight weeks.

Mild to moderate symptoms may include:

• Skin rash, hives (urticaria), or itching

• Redness or flushing of the skin

• Swelling, particularly around the face, lips, or eyes (angioedema)

• Runny nose or watery eyes

• Nausea or abdominal discomfort

Severe symptoms requiring immediate medical attention (call 999) include:

• Difficulty breathing or wheezing

• Swelling of the throat or tongue

• A sudden drop in blood pressure

• Rapid or irregular heartbeat

• Dizziness, confusion, or loss of consciousness

The most serious form of medication allergy is anaphylaxis, a potentially life-threatening systemic reaction that constitutes a medical emergency. According to NHS and Resuscitation Council UK (RCUK) guidance, anaphylaxis requires immediate administration of adrenaline (epinephrine) by intramuscular injection into the anterolateral thigh, followed by an emergency call to 999. There is also a risk of biphasic reactions, where symptoms return hours after initial recovery, which is why hospital observation is important following any episode of anaphylaxis.

Red-flag features of severe cutaneous adverse reactions (SCARs) — which require urgent attendance at A&E or a 999 call — include:

• A widespread, rapidly spreading, or blistering rash

• Involvement of the mucous membranes (eyes, mouth, or genitals)

• Skin pain, peeling, or raw areas

• High fever, facial swelling, lymph node enlargement, or jaundice

If you develop any of these features after starting a new medicine, stop the medicine and seek emergency care immediately.

It is also important to note that ACE inhibitor–induced angioedema (swelling of the face, lips, or throat) is not IgE-mediated and requires urgent assessment and permanent discontinuation of the ACE inhibitor. Not all adverse drug reactions are allergic in nature; some drugs, such as opioids and vancomycin, can cause pseudo-allergic reactions that mimic allergy without true immune involvement. Accurate identification of the reaction type is important for future prescribing decisions.

How Medication Allergies Are Diagnosed in the UK

Diagnosing a medication allergy accurately is a specialist process that goes beyond simply noting a patient's self-reported history. NICE guideline CG183 and NHS England guidance acknowledge that allergy is frequently over-reported and under-investigated, which can lead to patients being unnecessarily denied effective treatments — for example, being labelled as penicillin-allergic when they may in fact tolerate it safely.

The diagnostic pathway begins with a structured clinical history, which should include:

• The suspected drug, dose, and route of administration

• The indication for which it was prescribed

• The nature, timing, and severity of the reaction

• Any treatment required at the time

• Previous tolerance of the same or related drugs

• Other concurrent medicines or exposures

Your GP will usually initiate this assessment and may refer you to a specialist allergy clinic if a true drug allergy is suspected.

Specialist investigations may include:

• Skin prick testing and intradermal testing — used to detect IgE-mediated sensitivity, particularly to penicillins and some other drugs; availability and reliability vary for drugs other than beta-lactams

• Patch testing — more appropriate for delayed-type reactions affecting the skin

• Specific IgE blood tests — available for a limited range of drugs; results must always be interpreted alongside the clinical history

• Drug provocation testing (DPT) — considered the gold standard, involving supervised administration of the suspected drug under controlled clinical conditions with full resuscitation facilities available; DPT is contraindicated in patients who have previously experienced a SCAR (such as SJS, TEN, or DRESS) and in those with severe uncontrolled asthma

For patients labelled as penicillin-allergic, de-labelling pathways — including history-based risk stratification and, where appropriate, a direct oral challenge — are recommended by the BSACI and NICE to safely remove inaccurate allergy labels.

Patients should be aware that unvalidated tests — such as IgG panels or hair analysis — are not recommended by UK guidance and should not be used to diagnose drug allergy. The British Society for Allergy and Clinical Immunology (BSACI) provides evidence-based guidelines to support clinicians in this process. Patients are encouraged to request formal allergy assessment rather than accepting an unverified drug allergy label, as this can significantly affect the quality and range of treatments available to them throughout their lives.

Treatment and Management Options Available on the NHS

The management of a medication allergy depends on the severity of the reaction and whether it is acute or part of longer-term care planning. In all cases, the suspected causative drug should be stopped immediately if an allergic reaction is identified or strongly suspected.

For mild to moderate reactions, treatment may include:

• Antihistamines (e.g., cetirizine or loratadine) to relieve itching, rash, and urticaria

• Topical corticosteroids for localised skin reactions

• Oral corticosteroids (e.g., prednisolone) for more widespread or persistent symptoms, under medical supervision

1. For anaphylaxis, follow the Resuscitation Council UK (RCUK) emergency steps:
2. Call 999 immediately
3. Administer adrenaline 500 micrograms (0.5 mg) intramuscularly (IM) as a 1:1,000 solution, injected into the anterolateral thigh as soon as possible — this is the single most important treatment
4. Position the patient carefully: lie flat with legs raised if possible; if breathing is difficult, allow the patient to sit up slightly with legs outstretched; do not allow the patient to stand or walk; if pregnant, position in the left lateral (recovery) position
5. Administer a second dose of adrenaline after 5 minutes if there is no improvement
6. Antihistamines may be used as an adjunct for skin symptoms only; corticosteroids are not routinely recommended in the acute management of anaphylaxis per current RCUK guidance

Following anaphylaxis, hospital observation for at least 6 hours (or 12 or more hours in severe or high-risk cases) is recommended due to the risk of biphasic reactions, where symptoms may return after initial recovery.

After any significant allergic reaction, patients should be referred to an NHS allergy specialist for formal evaluation. Where a drug allergy is confirmed, the allergy must be clearly documented in the patient's medical records — including on the NHS Summary Care Record — in line with NICE CG183 requirements, to prevent inadvertent re-exposure. Patients who have experienced anaphylaxis should be prescribed two adrenaline auto-injectors (AAIs), receive training in their use, and be given a written emergency action plan.

In some cases, desensitisation protocols may be considered by specialists, particularly when a patient requires a drug to which they are allergic and no suitable alternative exists. This involves administering gradually increasing doses of the drug under close medical supervision to induce temporary tolerance. Desensitisation is a specialist-only procedure and is contraindicated in patients who have previously experienced a SCAR (such as SJS, TEN, or DRESS), given the risk of a severe and potentially fatal reaction on re-exposure.

How to Reduce Your Risk and Stay Safe

Whilst it is not always possible to predict or prevent a medication allergy, there are several practical steps patients and healthcare professionals can take to minimise risk and ensure safety.

For patients:

• Always inform your GP, pharmacist, dentist, and any other healthcare provider of any known or suspected drug allergies before starting a new medicine

• Carry a MedicAlert bracelet or similar medical identification if you have a confirmed serious drug allergy, particularly to penicillin or NSAIDs

• If you have been prescribed an adrenaline auto-injector (brands available in the UK include EpiPen and Jext), ensure you carry two devices at all times, know how to use them, check their expiry dates regularly, and make sure those around you know what to do in an emergency

• Do not assume that a reaction you experienced in the past was definitely an allergy — ask your GP about formal allergy testing, especially if you were labelled as penicillin-allergic in childhood, as many such labels are inaccurate

• Read medicine labels carefully, including over-the-counter products, and check with your pharmacist if you are unsure whether a product is safe for you

• If you develop a widespread, blistering, or painful rash, or any rash involving your eyes, mouth, or genitals after starting a new medicine, stop the medicine and go to A&E immediately or call 999

• Report suspected side effects or allergic reactions to any medicine — including vaccines — via the MHRA Yellow Card scheme (available at yellowcard.mhra.gov.uk). This helps the MHRA monitor medicine safety across the UK

For healthcare professionals, NICE guideline CG183 recommends that drug allergy labels are reviewed and verified regularly using a structured history, that patients are not denied first-line treatments based on unverified or poorly documented allergy histories, and that allergy details are recorded in a structured format — including the drug, reaction type, severity, and date — with written information provided to the patient.

If you experience any new or unexpected symptoms after starting a medicine — even if they seem minor — contact your GP promptly. If symptoms are severe, such as difficulty breathing, swelling of the throat, or collapse, call 999 immediately. Early intervention is the single most important factor in preventing serious outcomes from medication allergy. Staying informed, communicating openly with your healthcare team, and ensuring your allergy history is accurately recorded are the most effective ways to protect your long-term health and safety.

Frequently Asked Questions